Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medicare Rx Will Improve Coverage For 12 Mil. Seniors, Merck Says

Executive Summary

Merck expects the Medicare prescription drug benefit to enhance drug coverage for up to 12 mil. seniors

You may also be interested in...



Medicare Rx Cards Will Add $4.8 Bil. To Rx Sales In 2004, CIBC Estimates

The Medicare drug discount card will bring approximately $4.8 bil. in new revenue to the branded pharmaceutical industry in 2004, according to a CIBC analysis presented by Novartis VP-Business Development & Licensing Gary Cupit April 1 at an IIR conference in Philadelphia

Medicare Rx Cards Will Add $4.8 Bil. To Rx Sales In 2004, CIBC Estimates

The Medicare drug discount card will bring approximately $4.8 bil. in new revenue to the branded pharmaceutical industry in 2004, according to a CIBC analysis presented by Novartis VP-Business Development & Licensing Gary Cupit April 1 at an IIR conference in Philadelphia

Medicare Rx Becomes Law Dec. 8; Firms Analyzing Bill, PR Approaches

The signing of the Medicare prescription drug benefit legislation presents drug companies with the happy challenge of communicating the potential impact of the bill to investors without triggering a political backlash

Latest Headlines
See All
UsernamePublicRestriction

Register

PS042993

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel